Sound antitrust advice helps corporate leaders make informed decisions. Companies contemplating mergers, acquisitions, investments, and joint ventures need to know whether government enforcers are likely to challenge or delay a proposed transaction. Manufacturers and service providers need to structure their pricing, sales, and distribution strategies with compliance priorities in mind. Industry and trade association members need to understand where the antitrust boundaries lie. And, if the antitrust enforcers conduct a raid with the FBI, businesses need to know how to respond.
Alston & Bird’s antitrust team, with attorneys based in Washington, D.C., Atlanta, and San Francisco, can guide clients through these minefields – whether a deal is routine or complex, whether a business has years of compliance experience or is just getting started, and whether executives or entities are subject to civil or criminal investigations at the federal or state level.
Our attorneys have worked on many high-profile merger reviews and antitrust investigations over the past two decades, both in private practice and government service. Members of our team have previously served as senior officials at the U.S. Department of Justice (DOJ) under both Democratic and Republican administrations, and worked at the Federal Trade Commission (FTC) and with state attorneys general known for active antitrust enforcement. We offer valuable insights into the policies, processes, and priorities that drive today’s antitrust enforcement decisions so you can take the necessary steps to reduce regulatory risk and achieve your business goals.
Alston & Bird provides comprehensive antitrust representation. Our expanded regulatory practice, based in Washington, D.C., complements the firm’s prominent antitrust litigation practices based across the country. We advise leading U.S. and international corporations, mid-sized and startup companies, private equity firms, trade associations, and executives. Reflecting the firm’s complementary practice strengths, our antitrust team has extensive experience in the health care, pharmaceutical, financial services, private equity, technology, chemicals, telecommunications, and building products sectors.